Acumen Pharmaceuticals, Inc. - ABOS Net Assets per Single Share

Acumen Pharmaceuticals (ABOS) - corporate logo

Acumen Pharmaceuticals (ABOS) develops highly specialized antibodies against Alzheimer's disease, mitigating trial risks through dosage variability. The company's scientific potential is focused on innovative amyloid oligomer inhibitors ahead of the publication of Phase II data. This book value per share chart reflects a stepped growth in assets, where the parameter mark equals 0.48, underscoring a focus on eliminating the causes of brain degeneration to protect neurons.

Acumen Pharmaceuticals Inc. (ABOS) Equity per Share: for the period 07/04/2022 - 10/27/2026

acumenpharm.com - analytical breakdowns and key metrics (ABOS)

- price and consensus price forecast:
Price Chart Acumen Pharma|ABOS - Average Forecast Price
- market capitalization data:
Market Value Acumen Pharmaceuticals, Inc.|ABOS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Acumen Pharmaceuticals|ABOS - Accounting Capitalization|Market Capitalization to Book Value Ratio acumenpharm.com|ABOS - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Acumen Pharmaceuticals|ABOS - Long-Term Debt to Capital|Short-Term Debt to Equity Acumen Pharmaceuticals, Inc.|ABOS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Acumen Pharmaceuticals, Inc.
Fundamental company valuation:Acumen Pharma, ABOS
Manufactured products of Acumen Pharmaceuticals, Inc.

This indicator determines the residual value of capital per share by subtracting all liabilities from total assets to assess the intrinsic value of the business. The book value per common share trend for Acumen Pharmaceuticals (ABOS) reflects the volume of resources allocated to the development of Alzheimer's drugs rather than market conditions, as capital stability outweighs GDP cycles in this sector.

Competitors of Acumen Pharmaceuticals (ABOS)

BIIB (Biogen Corp) - Net Assets per Single Share|NBIX: Net Asset Value per Share|Regencell Bioscience - Net Assets per Single Share|AXSM (axsome.com) - Net Assets per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Trevi Corp (TRVI) - Net Asset Value per Share|PRAX (Praxis Precision Medicines) - Book Value per Share|Book Value per Share anavex.com|Book Value per Share CBLL (CeriBell)|Accounting Value per Share Prothena Corporation PRTA|Accounting Value per Share ALEC (Alector)|Annexon Biosciences Inc. - Book Value per Share|OMER: Net Assets per Single Share|NGNE - Accounting Value per Share|Book Value per Share ACIU|VYGR (Voyager Therapeutics Inc) - Net Asset Value per Share|Net Assets per Single Share Neumora Therapeutics Inc (NMRA)|Equity per Share Scilex Holding Company, Inc. (SCLX)|Tevogen Bio Holdings (TVGN) - Accounting Value per Share|Accounting Value of a Share ACOG (alphacognition.com)|Cognition Therapeutics (CGTX) - Net Assets per Single Share|Share Book Value Inhibikase Therapeutics Inc IKT|Book Value per Share Cassava (SAVA)|ASRT - Accounting Value of a Share|COYA: Book Value per Share|VTGN (Vistagen) - Book Value per Share|OVID - Net Assets per Single Share|Accounting Value of a Share CRVO|Net Assets per Single Share ATHE (Alterity Therapeutics)|Accounting Value per Share clene.com (CLNN)|Book Value per Share PEPG (PepGen)|Book Value per Share Jupiter Neurosciences, Inc. JUNS|RLMD: Book Value per Share|ANVS - Accounting Value per Share|Book Value per Share GRCE|Net Asset Value per Share Firefly Neuro|KLTO (ANEW Medical) - Accounting Value per Share|Book Value per Share NeuroSense Therapeutics, Ltd. (NRSN)|Accounting Value per Share Reviva Pharmaceuticals Holdings, Inc.|Book Price of a Share metaviatx.com (MTVA)|Book Value per Share NRXS|Net Assets per Share Helius Medical Technologies, Inc. HSDT|PASG: Book Value per Share|NEUP - Accounting Value per Share|NERV: Book Value per Share|ATHA (Athira Pharma Inc) - Book Value per Share|Net Assets per Single Share Addex Therapeutics, Ltd.|Net Assets per Single Share ALZN|CYCN (Cyclerion Therapeutics) - Net Assets per Single Share|Net Assets per Share protagenic.com (PTIX)|Book Value per Share KTTA (Pasithea Therapeutics Corp.)|Book Value per Share Cortigent Inc CRGT|ATXI - Book Value per Share|BCLI: Net Assets per Single Share|Net Assets per Single Share CARA|CHRO (chromocell.com) - Net Asset Value per Share|ELYM: Net Assets per Single Share|Net Assets per Share ITCI|Net Assets per Single Share Longboard Pharma LBPH|Equity per Share Marinus Pharma (MRNS)|NKGN: Book Value per Share|NRBO - Net Asset Value per Share|Sage Therapeutics - Accounting Value per Share|SNPX: Book Value per Share|Net Assets per Single Share Trevena, Inc TRVN|VIGL (Vigil Neuroscience, Inc.) - Accounting Value of a Share|Net Assets per Single Share WENA (Anew Medical)|Net Asset Value per Share cerevel.com